文献速递神经康复

卒中后无监督机器人辅助康复的可行性及对治疗剂量的影响

Unsupervised robot-assisted rehabilitation after stroke: feasibility, effect on therapy dose, and user experience.
PubMed 文献 · J Neuroeng Rehabil · 2024-04-09

该研究纳入亚急性期卒中患者,采用为期四周的方案:第一周为监督下每日45分钟机器人辅助治疗,第二周为最低限度监督,随后两周为完全无监督训练。结果显示13名受试者中12名可进入无监督训练,两周内平均额外完成360分钟机器人辅助康复,系统可用性量表平均分大于79,无不良事件或设备缺陷。

要点

  • 无监督机器人辅助上肢康复在临床环境中可行,13名受试者中12名能进入无监督训练。
  • 两周无监督训练平均额外增加360分钟机器人辅助康复治疗剂量。
  • 系统可用性量表平均分大于79,无不良事件或设备缺陷发生。

核心结论

  • 在临床环境中使用上肢驱动设备进行无监督机器人辅助治疗是可行的,并可带来有意义的治疗剂量增加。

研究设计与样本

  • 亚急性期卒中患者接受为期四周的方案,每日45分钟机器人辅助治疗,第一周监督下治疗,第二周最低限度监督,随后两周完全无监督训练。
  • 共招募13名受试者,评估可行性、无监督期间机器人辅助治疗剂量、用户体验及设备可用性。
  • 在最低限度监督周后和研究结束时分别进行可用性和用户体验问卷,以评估治疗师缺席的影响。

主要发现

  • 13名受试者中12名能够进展到无监督训练。
  • 在两周无监督治疗期间,参与者平均额外完成360分钟机器人辅助康复。
  • 参与者对设备可用性满意,系统可用性量表平均分大于79。
  • 未发生不良事件或设备缺陷。

临床怎么用

  • 无监督机器人辅助治疗可作为临床环境中常规护理的补充。
  • 该结果为进一步在家庭环境中应用无监督机器人辅助治疗奠定了基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unsupervised robot-assisted rehabilitation is a promising approach to increase the dose of therapy after stroke, which may help promote sensorimotor recovery without requiring significant additional resources and manpower. However, the unsupervised use of robotic technologies is not yet a standard, as rehabilitation robots often show low usability or are considered unsafe to be used by patients independently. In this paper we explore the feasibility of unsupervised therapy with an upper limb rehabilitation robot in a clinical setting, evaluate the effect on the overall therapy dose, and assess user experience during unsupervised use of the robot and its usability. METHODS: Subacute stroke patients underwent a four-week protocol composed of daily 45 min-sessions of robot-assisted therapy. The first week consisted of supervised therapy, where a therapist explained how to interact with the device. The second week was minimally supervised, i.e., the therapist was present but intervened only if needed. After this phase, if participants learnt how to use the device, they proceeded to two weeks of fully unsupervised training. Feasibility, dose of robot-assisted therapy achieved during unsupervised use, user experience, and usability of the device were evaluated. Questionnaires to evaluate usability and user experience were performed after the minimally supervised week and at the end of the study, to evaluate the impact of therapists' absence. RESULTS: Unsupervised robot-assisted therapy was found to be feasible, as 12 out of the 13 recruited participants could progress to unsupervised training. During the two weeks of unsupervised therapy participants on average performed an additional 360 min of robot-assisted rehabilitation. Participants were satisfied with the device usability (mean System Usability Scale scores > 79), and no adverse events or device deficiencies occurred. CONCLUSIONS: We demonstrated that unsupervised robot-assisted therapy in a clinical setting with an actuated device for the upper limb was feasible and can lead to a meaningful increase in therapy dose. These results support the application of unsupervised robot-assisted therapy as a complement to usual care in clinical settings and pave the way to its application in home settings. TRIAL REGISTRATION: Registered on 13.05.2020 on clinicaltrials.gov (NCT04388891).

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Devittori G, Dinacci D, Romiti D, et al. Unsupervised robot-assisted rehabilitation after stroke: feasibility, effect on therapy dose, and user experience. J Neuroeng Rehabil. 2024. PMID: 38594727. doi:10.1186/s12984-024-01347-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。